BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15785312)

  • 21. Leading cancers--changes in five-year relative survival.
    Ellison LF; Gibbons L
    Health Rep; 2004 Mar; 15(2):19-32. PubMed ID: 15151028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival outcomes of secondary cancers in patients with Waldenström macroglobulinemia: An analysis of the SEER database.
    Castillo JJ; Olszewski AJ; Kanan S; Meid K; Hunter ZR; Treon SP
    Am J Hematol; 2015 Aug; 90(8):696-701. PubMed ID: 25963924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of Breast, Prostate, and Colorectal Cancer Diagnoses Among HIV-Infected Individuals in the United States.
    Coghill AE; Engels EA; Schymura MJ; Mahale P; Shiels MS
    J Natl Cancer Inst; 2018 Sep; 110(9):959-966. PubMed ID: 29529223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How representative are colorectal, lung, breast and prostate cancer patients responding to the National Cancer Patient Experience Survey (CPES) of the cancer registry population in England? A population-based case control study.
    Alessy SA; Davies EA; Rawlinson J; Baker M; Lüchtenborg M
    BMJ Open; 2019 Dec; 9(12):e034344. PubMed ID: 31848175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology and trend of common cancers in Iran (2004-2008).
    Amori N; Aghajani M; Asgarian FS; Jazayeri M
    Eur J Cancer Care (Engl); 2017 Sep; 26(5):. PubMed ID: 26811194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adherence to cancer screening guidelines across Canadian provinces: an observational study.
    Strumpf EC; Chai Z; Kadiyala S
    BMC Cancer; 2010 Jun; 10():304. PubMed ID: 20565862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Importance of comorbidity in head and neck cancer.
    Piccirillo JF
    Laryngoscope; 2000 Apr; 110(4):593-602. PubMed ID: 10764003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Using personal health insurance numbers to link the Canadian Cancer Registry and the Discharge Abstract Database.
    Zakaria D; Trudeau R; Sanmartin C; Murison P; Carrière G; MacIntyre M; Turner D; Wagar B; King MJ; Vriends K; Woods R; Lockwood G; Louchini R
    Health Rep; 2015 Jun; 26(6):3-11. PubMed ID: 26086334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changing Epidemiology of Common Cancers in Southern Iran, 2007-2010: A Cross Sectional Study.
    Masoompour SM; Lankarani KB; Honarvar B; Tabatabaee SH; Moghadami M; Khosravizadegan Z
    PLoS One; 2016; 11(5):e0155669. PubMed ID: 27219458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
    Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
    J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjusting relative survival estimates for cancer mortality in the general population.
    Ellison LF
    Health Rep; 2014 Nov; 25(11):3-9. PubMed ID: 25408490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medicare Spending for Breast, Prostate, Lung, and Colorectal Cancer Patients in the Year of Diagnosis and Year of Death.
    Chen CT; Li L; Brooks G; Hassett M; Schrag D
    Health Serv Res; 2018 Aug; 53(4):2118-2132. PubMed ID: 28748564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer incidence, mortality and survival trends in Canada, 1970-2007.
    Kachuri L; De P; Ellison LF; Semenciw R;
    Chronic Dis Inj Can; 2013 Mar; 33(2):69-80. PubMed ID: 23470172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimates of cancer burden in Marche.
    Tavilla A; Vitarelli S; Rossi S; Foschi R
    Tumori; 2013; 99(3):351-8. PubMed ID: 24158064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regional and temporal variation in receipt of long-term opioid therapy among older breast, colorectal, lung, and prostate cancer survivors in the United States.
    Gibson DC; Raji MA; Baillargeon JG; Kuo YF
    Cancer Med; 2021 Mar; 10(5):1550-1561. PubMed ID: 33423372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimates of cancer burden in Lombardy.
    Gatta G; Ciampichini R; Bisanti L; Contiero P; Tessandori R; Baili P; Rossi S
    Tumori; 2013; 99(3):277-84. PubMed ID: 24158056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer patterns among women in the United States.
    Devesa SS
    Semin Oncol Nurs; 1995 May; 11(2):78-87. PubMed ID: 7604194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Understanding population-based site-specific cancer incidence rates in the USA.
    Merrill RM; Sloan A; Novilla LB
    J Cancer Educ; 2012 Jun; 27(2):263-8. PubMed ID: 21874603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stat bite: Probability of developing invasive cancers over selected ages, 2000-2002.
    J Natl Cancer Inst; 2006 Jun; 98(12):805. PubMed ID: 16788151
    [No Abstract]   [Full Text] [Related]  

  • 40. Cancer incidence in patients with hereditary hemorrhagic telangiectasia.
    Duarte CW; Black AW; Lucas FL; Vary CP
    J Cancer Res Clin Oncol; 2017 Feb; 143(2):209-214. PubMed ID: 27638773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.